Contracts Finder · Award

RADIOPHARMACEUTICALS AND GENERATORS

A public procurement published by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST via Contracts Finder.

Contracts FinderAward
£1.1m
Award value
£1.1m
Tender value
2
Suppliers
2
Awards
1
Notices
Award
Stage

Overview

For the supply of radiopharmaceuticals and associated consumables. The Trust has awarded the contract via North of England Commercial Procurement Collaborative Framework Agreement.

Key details

Source
Contracts Finder
Lifecycle stage
Award
Status
complete
CPV classification
09344000 — Radio-isotopes
Currency
GBP
Total award value
£1,052,733
Tender value
£1,052,733
First published
11 Jun 2019
Last updated
11 Jun 2019
View the original notice

Awards

2 awards recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
Curium Pharma25 Apr 2019active£1.1m
GE Healthcare LTD0100261025 Apr 2019active£1.1m

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award noticeRADIOPHARMACEUTICALS AND GENERATORS

All suppliers

Frameworks & programmes

More from HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST

FAQs about this procurement

Who is the buyer for "RADIOPHARMACEUTICALS AND GENERATORS"?

RADIOPHARMACEUTICALS AND GENERATORS is a UK public-sector procurement published by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST via Contracts Finder.

Has "RADIOPHARMACEUTICALS AND GENERATORS" been awarded?

Yes — 2 awards are recorded, with a reported total value of £1,052,733. The current lifecycle stage is "Award".

Which suppliers are involved in "RADIOPHARMACEUTICALS AND GENERATORS"?

2 suppliers are linked: Curium Pharma, GE Healthcare LTD.

What is "RADIOPHARMACEUTICALS AND GENERATORS" worth?

The reported award value is £1,052,733.

When was "RADIOPHARMACEUTICALS AND GENERATORS" published?

It was first published on 11 Jun 2019 and last updated on 11 Jun 2019, across 1 notice.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable